genome diagnostics private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 18 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 4 bids — GCC BIOTECH (INDIA) PRIVATE LIMITED. appeared in 3 of them.
GENOME DIAGNOSTICS PRIVATE LIMITED
GENOME DIAGNOSTICS PRIVATE LIMITED
Financial Details
Registered Office
G-167B, G BLOCK, FIRST FLOOR, STREET NO. 1, HARI NAGARNA-NEW DELHI-Delhi-110058-India
Industry Classification
Manufacturing (Metals & Chemicals, and products thereof)
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
10
Contract Value
₹8.52 Cr
L1 Bids
1
Recent Win Rate
0.0%
Performance Analytics
Genome Diagnostics Private Limited: Comprehensive Business Analysis
Genome Diagnostics Private Limited is navigating India's government tender ecosystem, participating in 10 tenders and achieving a 10% win rate. This business analysis provides a detailed overview of their financial performance, competitive landscape, and strategic opportunities within the diagnostics sector. It examines their tender participation, qualification rates, and procurement strategies to identify areas for improvement and growth.
Executive Summary
Genome Diagnostics Private Limited exhibits promising potential within the government tender market, evidenced by their ability to secure ₹8,52,11,271.0 in government contracts despite a low win rate. This report assesses their financial performance, conducts a competitive analysis against key players like GCC Biotech, and presents a SWOT analysis to guide future strategies. Key findings reveal opportunities to enhance bid efficiency, target high-value departments, and refine their competitive positioning within the diagnostics industry. Their current financial health is rated as 'Critical' with a score of 22.2/100.
Financial Performance Analysis
This section analyzes Genome Diagnostics' financial performance in securing government tenders. We delve into key metrics such as total contract value, win rates, and bid distributions to provide a clear understanding of their financial standing.
Key Financial Metrics
- Total Contract Value Secured: ₹8,52,11,271.0